A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project. Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials
Read More
Besides their names, there are a lot more similarities that could one day be unlocked between tech unicorn CM.com (AMS: CMCOM), which recently surpassed USD $1 billion market cap, and microcap artificial intelligence company Crowd Media (ASX: CM8). Both conversational commerce companies are headquartered in the Netherlands with CM.com having just surpassed the billion dollar
Read More
COVID-19 represents unchartered territory for everyone. Governments and various organisations across the globe have struggled to develop systems, policies and coordinate programs whilst researchers have scrambled to pull together clinically valid trials to deepen our understanding of our latest threat. ResApp (ASX: RAP) is a digital health company developing smartphone apps for both the diagnosis
Read More
Mask-ne, iso skin, whatever the beauty blogs have dubbed it, acne sucks. Yes, one of the many irritating side effects of this pesky pandemic is the resurgence of my teenage skin. Regular mask wearing and heightened stress has contributed to my new spotty appearance. Sadly, my bathroom wouldn’t make for a very good “shelfie” these
Read More
Having looked after ourselves through the pandemic as evidenced by their $16.5 million in sex toy sales over the past year, quasi-explorer Delecta (ASX: DLC) is seeking to multiply that revenue in the form of rising uranium prices. Yes, you did read that right. While dabbling in mineral exploration, Delecta has continued to operare its
Read More
I know, I know. We’re all sick of hearing news about the C word. Disgruntled Melbournians and aggrieved Sydneysiders aside, several companies are experiencing revenue boosting tailwinds from the pandemic situation. Respiratory technology company, Rhinomed (ASX: RNO) has received an initial purchase order from the Victorian Department of Health for one million Rhinoswabs to further
Read More
Given the massive amounts of money wagered by professional punters that utilise algorithms designed around sports statistics, tech company SportsHero (ASX: SHO) is trying their hand at eSports with a ‘Predictor’ they claim can exploit bookmaker mispricings of eSports matches. The Predictor, which they label as state-of-the-art, correctly predicted 125 match winners out of 189
Read More
Readying for the resumption of normal life as foot traffic increases, entertainment company ISA Group (ASX: IDZ) has confirmed it will be launching its fourth virtual reality entertainment centre in one of Sydney’s busiest shopping districts in November 2021. The FREAK Entertainment venue will be located in the entertainment section of Macquarie Centre in Sydney,
Read More
Chronic respiratory disease is a growing concern, especially in the age of COVID-19, with a snowballing amount of studies examining the effects of ‘long COVID’- where symptoms persist long after the virus has cleared. Medtech company Adherium (ASX: ADR) has what could be a very relevant and consequently very profitable suite of products designed to
Read More
